Analyst consensus rating
Korro Bio Analyst Rating: Strong Buy
Direct answer
Korro Bio's consensus rating is Strong Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $20.20.
Forecast evidence checked October 19, 2026.
Get free Korro Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $8.49
- Average price target
- $20.20
- High price target
- $30.00
- Low price target
- $10.00
- Low target gap
- +17.8%
- Target upside
- +137.9%
- High target gap
- +253.4%
- Target range width
- 235.6%
- Consensus rating
- Strong Buy
- Analysts
- 10
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Korro Bio?
Korro Bio has a verified Strong Buy consensus. The same dataset has an average price target of $20.20.
How far are Korro Bio's low and high targets from the recorded price?
The low target implies +17.8%, while the high target implies +253.4%.
How many analysts are included in Korro Bio's consensus?
The verified consensus includes 10 analysts.
How is Korro Bio's target upside or downside calculated?
The average target of $20.20 is divided by the recorded price of $8.49, then one is subtracted to produce +137.9%. This does not guarantee a future return.
When was Korro Bio's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.